MEDP
Medpace Holdings, Inc.Company Information
- Company Name
- Medpace Holdings, Inc.
- CIK
- CIK0001668397
- Category
- Large accelerated filer
- Ticker: Exchange
- MEDP: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8731
- SIC Description
- Services-Commercial Physical & Biological Research
- Ticker
- MEDP
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-02-27
- Last sale
- 2026-09-28
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 447,877
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 21,581,489
- Shares outstanding
- 28,174,000
- Ownership
- 76.60%
Earnings Market Reaction
- Filing date
- 2026-07-23
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 503 | 653 | 497 | 285 | 46 | 441 | 669 | 657 | 511 | 407 | 245 | 95 | ||||||
| Receivables Net Current | 442 | 395 | 402 | 373 | 378 | 298 | 296 | 311 | 301 | 279 | 298 | 293 | ||||||
| Prepaid Expense And Other Assets Current | 106 | 92 | 90 | 79 | 97 | 82 | 63 | 64 | 61 | 59 | 50 | 61 | ||||||
| Assets Current | 1,050 | 1,139 | 990 | 737 | 521 | 821 | 1,029 | 1,033 | 873 | 745 | 594 | 449 | ||||||
| Property Plant And Equipment Net | 157 | 137 | 131 | 133 | 135 | 128 | 124 | 124 | 122 | 119 | 121 | 115 | ||||||
| Operating Lease Right Of Use Asset | 126 | 127 | 118 | 124 | 130 | 130 | 129 | 131 | 134 | 139 | 145 | 144 | ||||||
| Goodwill | 662 | 662 | 662 | 662 | 662 | 662 | 662 | 662 | 662 | 662 | 662 | 662 | ||||||
| Intangible Assets Net Excluding Goodwill | 33 | 33 | 33 | 34 | 34 | 34 | 34 | 35 | 35 | 35 | 36 | 36 | ||||||
| Deferred Income Tax Assets Net | 3 | 3 | 19 | 37 | 66 | 100 | 100 | 77 | 75 | 75 | 74 | 59 | ||||||
| Other Assets Noncurrent | 25 | 28 | 22 | 26 | 24 | 22 | 22 | 23 | 18 | 20 | 25 | 21 | ||||||
| Assets | 2,057 | 2,130 | 1,975 | 1,753 | 1,572 | 1,897 | 2,101 | 2,084 | 1,920 | 1,796 | 1,657 | 1,487 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 38 | 34 | 28 | 27 | 43 | 61 | 33 | 26 | 27 | 24 | 32 | 29 | ||||||
| Accrued Liabilities Current | 451 | 406 | 408 | 369 | 324 | 286 | 308 | 307 | 293 | 271 | 293 | 265 | ||||||
| Contract With Customer Liability Current | 905 | 856 | 854 | 834 | 809 | 719 | 711 | 671 | 638 | 617 | 560 | 519 | ||||||
| Short Term Borrowings | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Other Liabilities Current | 42 | 48 | 53 | 54 | 45 | 56 | 54 | 37 | 35 | 45 | 40 | 36 | ||||||
| Liabilities Current | 1,435 | 1,345 | 1,344 | 1,284 | 1,220 | 1,122 | 1,105 | 1,041 | 993 | 957 | 925 | 849 | ||||||
| Operating Lease Liability Noncurrent | 120 | 122 | 114 | 119 | 125 | 127 | 126 | 128 | 132 | 136 | 142 | 143 | ||||||
| Deferred Income Tax Liabilities Net | 8 | 4 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | ||||||
| Other Liabilities Noncurrent | 60 | 60 | 58 | 54 | 52 | 53 | 43 | 31 | 29 | 29 | 28 | 23 | ||||||
| Liabilities | 1,623 | 1,531 | 1,516 | 1,459 | 1,399 | 1,304 | 1,275 | 1,203 | 1,156 | 1,124 | 1,098 | 1,016 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Treasury Stock Common Value | -12 | -12 | -12 | -12 | -12 | -12 | -12 | -12 | -12 | -12 | -12 | -12 | ||||||
| Additional Paid In Capital Common Stock | 964 | 953 | 936 | 907 | 893 | 887 | 844 | 837 | 819 | 815 | 803 | 796 | ||||||
| Retained Earnings Accumulated Deficit | -511 | -336 | -460 | -596 | -703 | -270 | 8 | 66 | -31 | -119 | -222 | -300 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -7 | -7 | -5 | -6 | -6 | -12 | -15 | -9 | -13 | -12 | -10 | -13 | ||||||
| Stockholders Equity | 434 | 598 | 459 | 294 | 172 | 594 | 826 | 881 | 764 | 672 | 559 | 471 | ||||||
| Liabilities And Stockholders Equity | 2,057 | 2,130 | 1,975 | 1,753 | 1,572 | 1,897 | 2,101 | 2,084 | 1,920 | 1,796 | 1,657 | 1,487 | ||||||
| Related Party | -0 | 3 | 4 | 1 | -1 | 3 | 4 | 7 | 1 | 2 | 2 | -2 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | ||||||
| Common Stock Shares Issued | 28 | 29 | 28 | 28 | 28 | 30 | 31 | 31 | 31 | 31 | 31 | 31 | ||||||
| Shares Outstanding | 28 | 29 | 28 | 28 | 28 | 30 | 31 | 31 | 31 | 31 | 31 | 31 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialMedpace Holdings, Inc. (MEDP) — SEC Financial Statements & Analysis
Medpace Holdings, Inc. (MEDP) is a services-commercial physical & biological research company, incorporated in DE. Medpace Holdings, Inc. trades on Nasdaq as: MEDP. Medpace Holdings, Inc. (MEDP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-23. Based on that filing, Medpace Holdings, Inc. carries a market cap of $14.92B, a P/E ratio of 30.36x, a P/B ratio of 34.39x, a P/S ratio of 5.36x, an enterprise value of $14.42B, and an EV/EBITDA multiple of 23.62x. On profitability, it posts an operating margin of 20.97%, a net margin of 17.67%, a Return on Equity (ROE) of 162.15%, a Return on Assets (ROA) of 27.09%, and a Return on Invested Capital (ROIC) of 421.90%. Per share, it reports EPS of $17.45, diluted EPS of $17.21, free cash flow per share of $25.08, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 24.67% year-over-year, net income growth of 17.50% year-over-year, and EPS growth of 19.28% year-over-year. On the balance sheet, it maintains a current ratio of 0.73x, a quick ratio of 0.66x, working capital of $-385.14M, a debt-to-equity ratio of 3.74x, a debt ratio of 0.79, an interest coverage ratio of 38.03x, free cash flow of $706.69M (TTM), and net debt of $-502.69M. Figures sourced from SEC EDGAR.
- Market Cap
- $14.92B
- P/E TTM
- 30.36x
- EPS TTM
- $17.45
- P/B TTM
- 34.39x
- ROE TTM
- 162.15%
- ROA TTM
- 27.09%
- Debt To Equity
- 3.74x
- Free Cash Flow TTM
- $706.69M
- Net Revenue TTM Growth 1Y
- 24.67%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Medpace Holdings, Inc. in?
Medpace Holdings, Inc. (MEDP) operates in the Services-Commercial Physical & Biological Research industry.
What exchange does MEDP trade on?
Medpace Holdings, Inc. (MEDP) trades on the Nasdaq.
Where is Medpace Holdings, Inc. incorporated?
Medpace Holdings, Inc. is incorporated in DE.
When was Medpace Holdings, Inc. (MEDP)'s most recent SEC filing?
Medpace Holdings, Inc. (MEDP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-23.
What is MEDP's market cap?
Medpace Holdings, Inc. (MEDP) has a market capitalization of $14.92B as of 2026-06-30.
What is MEDP's P/E ratio?
Medpace Holdings, Inc. (MEDP)'s trailing twelve month P/E ratio is 30.36x as of 2026-06-30.
What is MEDP's EPS (earnings per share)?
Medpace Holdings, Inc. (MEDP)'s trailing twelve month EPS is $17.45 as of 2026-06-30.
What is MEDP's ROE (return on equity)?
Medpace Holdings, Inc. (MEDP)'s trailing twelve month Return on Equity (ROE) is 162.15% as of 2026-06-30.
What is MEDP's ROA (return on assets)?
Medpace Holdings, Inc. (MEDP)'s trailing twelve month Return on Assets (ROA) is 27.09% as of 2026-06-30.
What is MEDP's ROIC (return on invested capital)?
Medpace Holdings, Inc. (MEDP)'s trailing twelve month Return on Invested Capital (ROIC) is 421.90% as of 2025-12-31.
What is MEDP's EV/EBITDA?
Medpace Holdings, Inc. (MEDP)'s trailing twelve month EV/EBITDA is 23.62x as of 2026-06-30.